SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback